1 / 18

ABNORMAL UTERINE BLEEDING

ABNORMAL UTERINE BLEEDING . Fawaz Edris MD, RDMS, FRCSC, FACOG, AAACS. INTRODUCTION . 1/3 of outpatient visits Most after menarche or perimenopausal Multiple causes, but mostly: Pregnancy related (always R/O) Structural uterine pathology ( fibroids , polyps, adenomyosis) Anovulation

neo
Télécharger la présentation

ABNORMAL UTERINE BLEEDING

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. ABNORMAL UTERINE BLEEDING Fawaz Edris MD, RDMS, FRCSC, FACOG, AAACS

  2. INTRODUCTION • 1/3 of outpatient visits • Most after menarche or perimenopausal • Multiple causes, but mostly: • Pregnancy related (always R/O) • Structural uterine pathology (fibroids, polyps, adenomyosis) • Anovulation • Disorder of hemostasis • Neoplasia • Trauma • Infection • More than 1 !! (myoma + cancer) • Non gynecological source (urethra, rectum)

  3. MENSTRUAL CYCLE • Mechanism: Estrogen  Ovulation  Preogesteron  withdrawal  menstruation • 24 - 35 days, lasting 2 to 7 days, flowing <80 mL/cycle • Predictable cyclic menses reflect regular ovulation • DUB vs. AUB • DUB: anovulation – no anatomical or systemic disease – by exclusion

  4. PATTERNS OF AUB • Menorrhagia: excessive (>80 mL/cycle) or prolonged menstrual bleeding (>7 days) • Amenorrhea: absence of bleeding ≥ 3 usual cycles • Oligomenorrhea: bleeding with interval > 35 days • Polymenorrhea: bleeding with interval < 24 days • Metrorrhagia: light bleeding at irregular intervals • Menometrorrhagia: heavy bleeding at irregular intervals • Intermenstrual bleeding: bleeding between menses • Premenstrual spotting: light bleeding preceding menses • Post coital spotting: vaginal bleeding within 24h of intercourse

  5. HISTORY  • What is the nature of the bleeding (frequency, duration, volume, relationship to activities such as coitus) • Quantity – number of pads, soakness • Intermenstrual bleeding - structural lesion (endometrial polyp, fibroid, cervical neoplasia) • Menometrorrhagia - anovulatory bleeding • Regular cyclic periods – ovulatory • Menorrhagea - bleeding diathesis, fibroid, adenomyosis.

  6. HISTORY • Are there symptoms of ovulation? (molimina) • When did the bleeding start? • Menorrhagia since menarche - Bleeding diathesis • Perimenarcheal and perimenopausal - Anovulation • Perimenopausal - polyps, adenomyosis, and fibroids • Were there precipitating factors, such as trauma?

  7. HISTORY • Any associated symptoms? • Lower abdominal pain, fever, vaginal discharge - infection (endometritis, vaginitis) • Changes in bladder or bowel function - mass effect from a local neoplasm or nonuterine bleeding • Headaches, breast discharge, visual disturbances - prolactinoma or other cranial tumor • Hirsutism or hair loss, acne – PCOS • Cold or Hot intolerence, Constipation or diarrhea - thyroid disease

  8. HISTORY • Is there a personal or family history of a bleeding disorder? • bleeding associated with surgery, dental extraction, childbirth, or bruising (>5 cm)/epistaxis/bleeding gums once or twice a month • Does she have a systemic disorder? • chronic liver or renal disease, thrombocytopenia - menorrhagia • Any medications? • Anticoagulants – menorrhagia • IUCD or OCP - intermenstrual bleeding

  9. HISTORY • Is she having coital relations? • Pregnancy related • Always do pregnancy test • Change in weight, eating disorder, excessive exercise, illness, or stress? • Anovulatory bleeding

  10. PHYSICAL EXAMINATION  • Speculum and pelvic examinations • Bleeding site: vulva, vagina, cervix, urethra, or anus • Any suspicious findings (mass, laceration, ulceration, vaginal discharge, foreign body) • Assess the size, contour, and tenderness of the uterus • fibroids, adenomyosis, pregnancy, or infection • Examine the adnexa for an ovarian tumor • Evaluate for pain - infection

  11. PHYSICAL EXAMINATION  • General examination • Signs of systemic illness, such as fever • Ecchymoses • Enlarged thyroid gland • Hyperandrogenism (hirsutism, acne, clitoromegaly, or male pattern balding) • Acanthosis nigricans - insulin resistance and anovulation. • Galactorrhea - hyperprolactinemia.

  12. LABORATORY EVALUATION • Pregnancy test in all reproductive age women • Intrauterine pregnancy • Ectopic • Gestational trophoblastic disease • Cervical cytology  • Any visible cervical lesion should be biopsied

  13. LABORATORY EVALUATION • Endometrial biopsy - endometrial cancer hyperplasia •  All women > 35 years • 18 and 35 years if with risk factors for endometrial cancer (family or personal history of ovarian, breast, colon, or endometrial cancer; tamoxifen use; chronic anovulation; obesity; estrogen therapy; prior endometrial hyperplasia; diabetes) • Always r/o pregnancy then do in second half of cycle • Secretory endometrium - ovulation • Proliferative endometrium – anovulation • Inflammation of the endometrium - endometritis

  14. ADDITIONAL LAB. EVALUATION   • Hemoglobin/hematocrit  • TSH • Coagulation tests  • Platelet count – thrombocytopenia • Coagulation testing - PTT, PT, factor VIII, and von Willebrand factor antigen and activity • STD: Gonorrhea, Chlamydia, trichomonads • Prolactin level  • Androgen levels: Testosterone, DHEAS

  15. ADDITIONAL LAB. EVALUATION   • Ultrasound • Fibroids, adenomyosis, endometrial lining, ovaries • Saline infusion sonography (sonohysterography) • Fibroids, polyps • Hysteroscopy 

  16. MANAGEMENT  • Is bleeding ovulatory or anovulatory?  • Ovulatory  treat the underlying cause • Anovulatory • Acute management • Estrogen: Oral or IV • D&C (temporary measure – not therapeutic) • Ongoing management • Replace Progesterone • Progesterone: pills (continuous or cyclical), injections • OCP • Other measures • Thin the endometriam: hormonal IUCD • Remove the endometriam: Ablation • Remove the organ: Hysterectomy

  17. MANAGEMENT  • If bleeding persists after treatment • Additional etiologies  continue to evaluate

  18. Thank you

More Related